EA200870379A1 - Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер - Google Patents
Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимерInfo
- Publication number
- EA200870379A1 EA200870379A1 EA200870379A EA200870379A EA200870379A1 EA 200870379 A1 EA200870379 A1 EA 200870379A1 EA 200870379 A EA200870379 A EA 200870379A EA 200870379 A EA200870379 A EA 200870379A EA 200870379 A1 EA200870379 A1 EA 200870379A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- polymer
- pharmaceutical composition
- slowed
- system including
- acid soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Abstract
Фармацевтическая композиция замедленного высвобождения, включающая по меньшей мере один плохо растворимый активный агент, по меньшей мере один солюбилизатор, регулирующую скорость высвобождения полимерную систему, состоящую из кислоторастворимого полимера и рН-независимого полимера, и, необязательно, другие фармацевтически приемлемые вспомогательные вещества. Настоящее изобретение описывает также способ приготовления таких композиций и способ применения таких композиций. Композиции замедленного высвобождения полезны для обеспечения терапевтически эффективных концентраций активного агента (активных агентов) в течение более длительных периодов времени.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN832DE2006 | 2006-03-27 | ||
PCT/IN2007/000110 WO2007110878A1 (en) | 2006-03-27 | 2007-03-19 | Sustained release pharmaceutical composition on the basis of a release system comprising an acid-soluble polymer and a ph-dependent polymer. |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200870379A1 true EA200870379A1 (ru) | 2009-04-28 |
Family
ID=38540835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200870379A EA200870379A1 (ru) | 2006-03-27 | 2007-03-19 | Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100234288A1 (ru) |
EP (1) | EP2004150A1 (ru) |
JP (1) | JP2009531420A (ru) |
CN (1) | CN101410096A (ru) |
AU (1) | AU2007230549A1 (ru) |
BR (1) | BRPI0709222A2 (ru) |
CA (1) | CA2647421A1 (ru) |
CR (1) | CR10404A (ru) |
EA (1) | EA200870379A1 (ru) |
MA (1) | MA30359B1 (ru) |
MX (1) | MX2008012486A (ru) |
RS (1) | RS20080439A (ru) |
TN (1) | TNSN08365A1 (ru) |
WO (1) | WO2007110878A1 (ru) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5222550B2 (ja) * | 2007-12-27 | 2013-06-26 | 財團法人工業技術研究院 | 徐放性組成物およびその製造方法 |
WO2009113051A2 (en) * | 2008-03-12 | 2009-09-17 | Dexcel Ltd. | Oral modified-release formulations containing thiazepines |
EP2108365A1 (en) * | 2008-04-09 | 2009-10-14 | LEK Pharmaceuticals d.d. | Single dosage pharmaceutical formulation comprising eprosartan mesylate |
US20110189279A1 (en) * | 2008-08-11 | 2011-08-04 | Ratiopharm Gmbh | Pharmaceutical compositions with modified release properties comprising 5-chloro-n-(-methyl)-2-thiophencarboxamid |
CN101361979B (zh) * | 2008-09-19 | 2011-01-19 | 天津博科林药品包装技术有限公司 | 一种固体制剂薄膜包衣剂及其制备方法 |
WO2010082855A1 (en) * | 2009-01-15 | 2010-07-22 | Zaklady Farmaceutyczne Polpharma Sa | Pharmaceutical compositions comprising ziprasidone free base or ziprasidone hydrochloride and the method for their preparation |
US9205577B2 (en) * | 2010-02-05 | 2015-12-08 | Allergan, Inc. | Porogen compositions, methods of making and uses |
US9138309B2 (en) | 2010-02-05 | 2015-09-22 | Allergan, Inc. | Porous materials, methods of making and uses |
WO2011103718A1 (zh) * | 2010-02-26 | 2011-09-01 | 上海沪美医药科技有限公司 | 一种含有喹硫平的控(缓)释制剂及其制备方法和用途 |
US11202853B2 (en) * | 2010-05-11 | 2021-12-21 | Allergan, Inc. | Porogen compositions, methods of making and uses |
EP2603207A2 (en) * | 2010-08-10 | 2013-06-19 | Lupin Limited | Oral controlled release pharmaceutical compositions of blonanserin |
MX359366B (es) * | 2010-11-01 | 2018-09-26 | Melinta Subsidiary Corp | Composición farmacéutica de liberación sostenida que comprene un agente antibacterial. |
CN102058517A (zh) * | 2010-12-31 | 2011-05-18 | 泰州万全医药科技有限公司 | 一种帕潘立酮缓释剂及其制备方法 |
US20150174247A1 (en) * | 2012-06-29 | 2015-06-25 | Maruishi Pharmaceutical Co., Ltd. | Oral pharmaceutical preparation of aripiprazole |
TWI722988B (zh) * | 2015-06-05 | 2021-04-01 | 瑩碩生技醫藥股份有限公司 | 緩釋性醫藥組合物及其製備方法 |
CN105199115B (zh) * | 2015-10-27 | 2021-01-12 | 中国林业科学研究院林产化学工业研究所 | 一种多孔渗水的三维网状结构的可注射水凝胶的制备及其应用 |
WO2017218772A1 (en) * | 2016-06-17 | 2017-12-21 | The Procter & Gamble Company | Delayed-release particles |
CN108203508A (zh) * | 2016-12-16 | 2018-06-26 | 中国石油化工股份有限公司 | 一种改性尼龙6材料及其制备方法 |
CN115813887A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
US11337932B2 (en) | 2016-12-20 | 2022-05-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
KR101813835B1 (ko) * | 2017-02-17 | 2017-12-29 | 이충근 | 피이지 프리 가용화제 및 이의 제조방법 |
CN107028903B (zh) * | 2017-05-03 | 2020-03-10 | 深圳万和制药有限公司 | 布南色林片剂药物组合物及其制备方法 |
CA3067938A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
BR112020011189A2 (pt) | 2017-12-05 | 2020-11-17 | Sunovion Pharmaceuticals Inc. | misturas não racêmicas e usos das mesmas |
EP3720435B1 (en) | 2017-12-05 | 2024-03-06 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
US11672781B2 (en) | 2018-05-07 | 2023-06-13 | Prana Biosciences Inc | Metaxalone formulations |
KR20210022656A (ko) | 2018-06-20 | 2021-03-03 | 에르테에스 로만 테라피-시스테메 아게 | 아세나핀을 함유하는 경피 치료 시스템 |
CN109984999B (zh) * | 2019-04-28 | 2021-12-24 | 重庆仁泽医药科技有限公司 | 一种药物组合物及其制备方法和用途 |
JP2022535893A (ja) | 2019-06-04 | 2022-08-10 | サノビオン ファーマシューティカルズ インク | 放出調節製剤およびその使用 |
CN111568856B (zh) * | 2020-06-24 | 2021-07-06 | 珠海舒桐医疗科技有限公司 | 一种阴道凝胶制剂及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
ES2333645T3 (es) * | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros. |
US20050096365A1 (en) * | 2003-11-03 | 2005-05-05 | David Fikstad | Pharmaceutical compositions with synchronized solubilizer release |
-
2007
- 2007-03-19 CN CNA2007800114250A patent/CN101410096A/zh active Pending
- 2007-03-19 WO PCT/IN2007/000110 patent/WO2007110878A1/en active Application Filing
- 2007-03-19 BR BRPI0709222-9A patent/BRPI0709222A2/pt not_active Application Discontinuation
- 2007-03-19 MX MX2008012486A patent/MX2008012486A/es unknown
- 2007-03-19 EP EP07736570A patent/EP2004150A1/en not_active Withdrawn
- 2007-03-19 CA CA002647421A patent/CA2647421A1/en not_active Abandoned
- 2007-03-19 RS RSP-2008/0439A patent/RS20080439A/sr unknown
- 2007-03-19 EA EA200870379A patent/EA200870379A1/ru unknown
- 2007-03-19 JP JP2009502333A patent/JP2009531420A/ja not_active Withdrawn
- 2007-03-19 AU AU2007230549A patent/AU2007230549A1/en not_active Abandoned
- 2007-03-19 US US12/294,482 patent/US20100234288A1/en not_active Abandoned
-
2008
- 2008-09-19 TN TNP2008000365A patent/TNSN08365A1/en unknown
- 2008-10-27 MA MA31337A patent/MA30359B1/fr unknown
- 2008-10-27 CR CR10404A patent/CR10404A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2004150A1 (en) | 2008-12-24 |
RS20080439A (en) | 2009-05-06 |
TNSN08365A1 (en) | 2009-12-29 |
AU2007230549A1 (en) | 2007-10-04 |
CR10404A (es) | 2008-12-08 |
JP2009531420A (ja) | 2009-09-03 |
CA2647421A1 (en) | 2007-10-04 |
WO2007110878A1 (en) | 2007-10-04 |
MA30359B1 (fr) | 2009-04-01 |
BRPI0709222A2 (pt) | 2011-07-12 |
CN101410096A (zh) | 2009-04-15 |
US20100234288A1 (en) | 2010-09-16 |
MX2008012486A (es) | 2008-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200870379A1 (ru) | Фармацевтическая композиция с замедленным высвобождением на основе системы высвобождения, включающей кислоторастворимый полимер и ph-зависимый полимер | |
EA200800161A1 (ru) | Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций | |
WO2007022255A3 (en) | Pharmaceutical formulations for sustained release | |
WO2008057802A3 (en) | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same | |
DK0991407T3 (da) | Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer | |
WO2008036147A3 (en) | Drug delivery with stimulus responsive biopolymers | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
WO2006089082A3 (en) | Transmucosal administration of drug compositions for treating and preventing disorders in animals | |
CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
WO2002074247A8 (en) | Pharmaceutical formulations for sustained release | |
NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
MXPA05010659A (es) | Formulaciones veterinarias antihelminticas topicas. | |
CY1109117T1 (el) | Διαμορφωσεις enaιωphmatoς, οι οποιες περιλαμβανουν δραστικον συστατικο, επιφανειακως δρωσαν ουσια poloxamer ή meroxapol και γλυκολη, χρησις του δια την βιομηχανικην παρασκευην φαρμακου προς νοσηλειαν οφθαλμικων διαταραχων | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
NO20080220L (no) | Formuleringer med hoy medikament belastning og doseringsformer | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
WO2008003028A3 (en) | Pharmaceutical compositions comprising droxidopa | |
MX2010005013A (es) | Composiciones intranasales. | |
WO2007085629A3 (en) | Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents | |
WO2006061715A3 (en) | Methylene inhibitors of matrix metalloproteinase | |
WO2006123364A3 (en) | Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative | |
DE602004005564D1 (de) | Pharmazeutische Zusammensetzung für Thrombinpeptidderivaten | |
NO20083183L (no) | Fast farmasoytisk sammensetning inneholdende irbesartan |